Preferred Imaging for Suspected Pulmonary Embolism
CT pulmonary angiography (CTPA) is the preferred initial imaging modality for suspected pulmonary embolism. 1
Primary Imaging Recommendation
CTPA should be obtained in all patients with high pretest probability of PE, and in patients with low or intermediate pretest probability who have elevated D-dimer levels. 1
CTPA has become the de facto clinical gold standard, replacing catheter pulmonary angiography and ventilation-perfusion scanning as first-line imaging. 2
The American College of Physicians explicitly recommends CTPA as the imaging modality of choice, with ventilation-perfusion scans reserved only for patients who have contraindications to CTPA or when CTPA is unavailable. 1
The British Thoracic Society guidelines similarly designate CTPA as the recommended initial lung imaging modality for non-massive PE. 1
Diagnostic Performance
Patients with a good quality negative CTPA do not require further investigation or treatment for PE. 1
Modern multidetector CTPA demonstrates sensitivities of 99-100% and specificities of 100% for detecting thromboembolic disease at the segmental level. 3
Clinical outcome studies demonstrate it is safe to withhold anticoagulation when PE is excluded on CTPA, with subsequent PE occurring in only 1.1% of patients at 3 months—comparable to the 0.9% recurrence rate after negative conventional angiography. 1
CTPA is clearly superior in specificity to ventilation-perfusion isotope scanning and allows quantitative assessment that correlates well with clinical severity. 1
Technical Advantages
CTPA enables direct visualization of intravascular thrombus, webs, bands, and vessel occlusion while simultaneously evaluating alternative diagnoses when PE is excluded. 1
Modern multidetector technology with thin-section collimation (2-3 mm slice thickness) provides excellent visualization of segmental and subsegmental vessels. 3, 4
CTPA demonstrates secondary effects including wedge-shaped opacities, right ventricular changes, and can assess for right ventricular dysfunction for prognostication. 1, 2
Dual-energy CT techniques improve detection through perfusion mapping and can rescue suboptimal contrast studies using monoenergetic images. 1
Alternative Imaging Modalities
Ventilation-Perfusion Scanning
V/Q scanning should be used only when CTPA is unavailable or contraindicated (e.g., contrast allergy, renal insufficiency). 1
V/Q scanning remains a valid alternative but has been largely supplanted by CTPA due to superior specificity and diagnostic clarity. 1
MR Angiography
MRA has limited utility for acute PE diagnosis, with the PIOPED III trial showing technically inadequate studies in 25% of patients and sensitivity of only 78% in adequate studies. 1
MRA combined with perfusion imaging can diagnose chronic thromboembolic disease with 83-100% sensitivity but has lower sensitivity for acute PE compared to CTPA. 1, 3
Echocardiography
Echocardiography (or CTPA) will reliably diagnose clinically massive PE and should be performed within 1 hour in massive PE. 1
Echocardiography allows firm diagnosis in only a minority of non-massive PE cases and is primarily useful for prognostic information rather than definitive diagnosis. 1
Critical Timing Considerations
Imaging should be performed within 1 hour in massive PE, and ideally within 24 hours in non-massive PE. 1
CTPA is now widely available in most hospitals and may be quicker to arrange than echocardiography, even out of hours. 1
Important Caveats
Adequate contrast timing is essential—standard scan delay is 15 seconds, but may require 15-30 seconds in patients with right ventricular failure or pulmonary hypertension. 3
Meticulous attention to technique is necessary to achieve contrast opacification of at least 210 Hounsfield units for optimal embolus detection. 5
A small proportion of examinations will be technically unsatisfactory; quality control is critical for reliable interpretation. 1
Subsegmental clot may be less reliably detected than proximal clot, though most patients with subsegmental PE also have more proximal clot that can be identified. 1
Interobserver agreement is good even with relatively inexperienced assessors, but familiarity with interpretation pitfalls and artifacts is essential to avoid false positives. 1, 5